Autolus
Matteo Righi, PhD, is a highly skilled scientist specializing in adoptive cell therapy technologies and synthetic biology. Currently serving as a Senior Scientist 1 at Autolus Ltd. since September 2015, Matteo focuses on enhancing engineered therapies. Prior roles include Senior Scientist 2 and PhD student in Haematology at University College London, where development of a signaling platform for T cells was a key responsibility. Other experience encompasses research roles in multiple institutions, including a Research Technician at UCL's Department of Haematology, and as a Technician in RealTime PCR at Cogentech. Matteo's educational background includes a PhD in Immunology from UCL, a Master’s in Drug Biotechnology, and a Bachelor’s in Pharmaceutical Biotechnology from Università degli Studi di Milano.